activated microglia into a tumor-promoting state at some point during tumor progression. Notably, we found that microglia could contribute to tumor invasion and acquisition of the epithelial-mesenchymal transition phenotype in the glioma microenvironment during the early stage and the late stage of tumor progression. In conclusion, we have developed a potential quantitative method for in vitro study of glioma immunity and provided evidence for the duality of glioma-associated microglia.
Introduction
Gliomas are the most common primary tumors that arise from glial cells within the central nervous system. Despite advances in surgery, radiotherapy and chemotherapy, glioblastoma multiforme, the most frequent type of malignant glioma, is still the deadliest cancer, with the median survival duration of <15 months [1, 2] . Various immunotherapeutic approaches have been conducted specifically against glioma, but none have proven effective [3] . It is likely that immunotherapy can only be effective after the immunosuppressive environment within the glioma's mass is overcome [4] .
Microglia, the resident macrophages in the central nervous system, occupy a key position in the coordination of active immune surveillance [5] . Microglia are the predominant infiltrating immune cells within glioma and contribute up to 30% of the total tumor mass [6, 7] . There have been many investigations concerning the interaction between microglia and gliomas. However, Abstract It has been proven that microglia are involved in both early and late stages of glioma progression and contribute substantially to the tumor mass of gliomas. Because no appropriate in vitro or in vivo investigative approach is available, the dynamic interaction between microglia and gliomas during tumor formation remains unclear. In this study, three types of microfluidic assay were developed to examine the outcomes of the dynamic interaction between microglia and gliomas. Co-migration assay and two-dimensional cell co-culture assay have been used to show that microglial BV-2 cells migrate toward C6 glioma cells and inhibit tumor growth during the early stage of tumorigenesis. However, in three-dimensional cell spheres (threedimensional cell co-culture assay) that contain a large amount of glioma cells, mimicking the late stage of glioma growth, the phagocytosis of microglia was suppressed, which suggests that glioma cells could reeducate classically Rui Gu and Xu Zhang contributed equally to this work. the issue of whether microglia suppress or enhance glioma growth remains controversial. Compelling evidence has shown that glioma cells could suppress the immune surveillance functions of microglia [8, 9] and respond to their products by increasing proliferation or invasion [10] . There also exist hints in support of gliomacytotoxic effects of microglia [11, 12] . The intracranial immune responses modulated by microglia may be much more diverse and dynamic than previously thought and may result in containment and exacerbation during the malignant process [9, 13, 14] . Due to a lack of physiologically relevant in vitro models and the challenges of investigating cell-cell interactions in vivo, the dynamics of glioma cells and microglia interactions throughout the course of tumor development remain poorly understood [4, 15] . In particular, a number of fundamental questions remain as to whether the glioma-promoting relationship between microglia and tumor cells is present during the early stage of the tumor process or whether the interplay between microglia and glioma cells changes during tumor progression. Progress in microfluidic technology has facilitated the in vitro study of cellular behavior under tightly controlled microenvironments with a defined spatiotemporal distribution, obviating the shortcomings of the traditional co-culture methods based on Transwell technique. Therefore, modeling the tumor microenvironment by integration of the interactions among different cell types on a micropatterned surface has become an attractive target of microfluidics. To this end, we and other groups have developed various microfluidic designs to study tumor invasion [16, 17] , tumorendothelial cell interactions [18] , and tumor-stromal cell interactions [19] .
In this study, we established three microfluidic assays for the systematic investigation of the reciprocal interaction between microglia and glioma cells. To assess the indirect interaction between microglia and glioma cells, a co-migration assay was developed, and the cellular behavior was monitored by microscopy. We then performed two-dimensional (2D) and three-dimensional (3D) cell co-culture assays to explore the microglia-glioma cell crosstalk during the early and late stages of the tumor process, respectively. Microglia contributed to the advanced invasiveness of glioma cells and tumor progression. However, effective tumor-suppressing capacity of microglia was observed in the 2D assay; thus, both anti-tumor and pro-tumor activities were exhibited at the same time. These results demonstrate the utility of our microfluidic approach for direct observation of the interaction between microglia and glioma cells and provide useful information to sway the balance toward limitation of tumor growth and clinical benefit.
Materials and Methods

Design and Fabrication of Microfluidic Devices
The migration chip was fabricated with the soft lithography method, as shown in Fig. 1a . The microfluidic device was a double-layered chip fabricated with polydimethylsiloxane (PDMS). The upper layer had seven paratactic migration channels, and the bottom layer was a flat PDMS substrate [20] . In the upper layer, each channel was 80 μm wide and 5 μm high. The depth of the channel was lower than the diameter of round cells (around 10 μm) but higher than the thickness after cell adherence (2-3 μm). The interval between the channels was 30 μm. Two inlets were located at each end of the migration channels for cell inoculation (Fig. 1b) .
A hollow-well array chip was introduced to generate the 2D-micropatterned assay to mimic the early stage of glioma progression. A structure diagram of the microfluidic device is shown in Fig. 1c . The PDMS chip was 10mm × 10mm × 1 mm (length × width × depth), with an array of 1-mm-diameter hollow wells that were formed using the micro-pillar array template.
The 3D-micropatterned assay was established on the basis of the concave array chip (Fig. 1d) . The concave array chip was also fabricated with a soft lithography method and was subsequently modified with a 0.2% Pluronic F-127 solution to prevent cell adhesion [21] .
Cell Culture on Microfluidic Devices
The immortalized mouse microglia cell line BV-2 (obtained from the Basic Medical Cell Culture Center, Chinese Academy of Medical Science & Peking Union Medical College, Peking, China) exhibits the morphological and functional characteristics of reactive microglial cells [22] . C6 cells from a rat brain glioma were purchased from the American Type Culture Collection (ATCC). Both BV-2 and C6 cells were maintained in Dulbecco's modified Eagle's medium (DMEM, Invitrogen) supplemented with 10% fetal calf serum and 1% penicillin/streptomycin at 37 °C in a humidified incubator under 5% CO 2 .
For the co-migration assay, a cell suspension was prepared with 2 × 10 6 cells/ml. BV-2 cells were inoculated into the seeding pool at one end of the chip, and C6 cells were placed in the other (Fig. 1b) . The seeding volume was 10 μl for each pool. After filling, the cells in the device were cultured in a static situation in an incubator at 5% CO 2 , and the medium was changed every day. For changing the media in the microchip, two pipettes were used to remove the media in both pools at the same time. Fresh media was then added simultaneously.
For the 2D co-culture assay, the hollow-well array chip was placed in a 35-mm cell culture dish (Fig. 1c ). C6 cells (3 × 10 5 /ml) were seeded onto the chip and incubated at 37 °C for 24 h to allow the cells to settle and attach to the substrate before the PDMS chip was peeled off. Finally, BV-2 cells (2 × 10 5 /ml) were added to the dish, thus forming the 2D co-culture assay to mimic the early stage of glioma progression. A 2D micropattern of C6 cells without BV-2 cells acted as a control. The area of invasion was defined as the zone with high density of C6 cells.
To establish the 3D co-culture assay, C6 cells (10 6 / ml) were seeded on the concave microdevice ( Fig. 1d ) in a 35-mm dish. The seeded microfluidic device was maintained in a humidified atmosphere of 95% air and 5% CO 2 at 37 °C for 24 h to form cell spheroids rather than inducing adhesion to the chip surface. This concave array chip was then turned over to release the cell spheroids onto the bottom of the dish. The released cell spheroids were cultured for another 3 days before adding a cell suspension of BV-2 cells (2 × 10 5 /ml), which formed the 3D co-culture cell spheroids to mimic the late stage of glioma progression. A 3D micropattern of C6 cells without BV-2 cells was used as a control. Also, the area of invasion was defined as the zone with high density of C6 cells.
Immunofluorescence Microscopy
The expression of CD11b, CD68, and vimentin was determined by immunofluorescence imaging. The co-culture devices were washed with PBS and fixed with 4% paraformaldehyde at room temperature for 30 min, followed by treatment with 0.1% Triton X-100 for 30 min. After washing three times with PBS, the cells were blocked with normal goat serum for 1h at room temperature and then incubated with mouse antivimentin antibody, rabbit anti-CD11/b antibody, and rabbit anti-CD68 antibody (Bioss, China) overnight at 4 °C. After washing three times with PBS, the cells were incubated with TRITC-conjugated goat anti-mouse antibodies (Zhongshan, China) and FITC-conjugated goat anti-rabbit IgG (Zhongshan, China) at room temperature for 1h. Nuclear staining was carried out using According to the manufacturer's instructions for the transcription kit, real-time PCR was performed with a Mx3000P qPCR system (Agilent Technologies, USA) with SYBR Premix Ex Taq (Takara). The oligonucleotide sequences for Twist1 and MMP-9, which are involved in tumor metastasis, were adapted from the literature [23] . The relative expression level of each gene was calculated using the comparative threshold cycle (C t ) method, and the housekeeping gene β-actin served as an internal standard. PCR amplification was performed as follows: 95 °C for 30 s, 40 cycles of denaturation (95 °C for 5 s), annealing (55 °C for 30 s), and extension (72 °C for 30 s).
Statistical Analysis
All data were confirmed in three independent experiments. The statistical significance of the differences between the treatment and control groups were analyzed using Student's t test with SPSS 12.0.
Results
Establishment of 2D and 3D Micropattern Assays of C6 Cells
The 2D and 3D micropatterns of C6 cells were achieved with the use of hollow-well array chips and concave array chips, respectively. As shown in Fig. 1e , the hollow-well array chips allowed the cells to grow in the well with normal morphology, and boundary bourn of each pattern area could be observed clearly. This result demonstrated the feasibility of this hollow-well array chip to pattern 2D cells in a controllable manner. We also generated 3D cell spheroids using a concave array chip. As shown in Fig. 1f , the cell spheroids formed in the chip equably and tightly with an excellent pattern. This concave array chip with cell spheroids was then turned over into the 35-mm culture dish to make the cell spheroids adhere to the substrate to form the 3D micropattern assay. 
BV-2 Cells Directional Migration Under the Chemotaxis of C6 Cells
To detect whether the microglia cells could be activated by glioma and whether they exhibited chemotactic migration toward them, we carried out a microfluidic co-migration assay of unattached, co-cultured BV-2 and C6 cells. The two types of cells were seeded onto the two chambers of the migration device, which were connected by migration channels (Fig. 1b) . Due to the lower depth of the migration channels, the non-adherent and round cells were blocked by the channels and could only migrate into the microchannels when the cells were attached and spread on the substrate. In this way, the cell number in the migration channels could denote the cells' migratory ability. As shown in Fig. 2a , the migration capability of both C6 and BV-2 cells was greater than that of the control group after the two kinds of cells were co-cultured for 48 h, which indicates that these two types of cells could be mutually chemoattracted and that the interaction between microglia and glioma cells in the glioma microenvironment is bidirectional.
Activation of BV-2 Cells Under Conditioned Media (CM) of C6 Cells
To determine the responses of microglia to glioma, we observed the activation of BV-2 cells under conditioned media (CM) of C6 cells. As shown in Fig. 2b , we designed three experimental groups: the BV-2 control group (BV-2 con, C6 CM free), BV-2 cells with 2D-cultured C6 CM group (BV-2 under 2D-CM), and BV-2 cells with 3D-cultured C6 CM group (BV-2 under 3D-CM). The results show that both 2D-CM and 3D-CM of C6 cells were able to induce the morphological transformation of BV-2 cells from a round to an amoeboid or mesenchymal shape, which was considered as the processed BV-2 cells (Fig. 2b i) . We then quantified the percentage of processed BV-2 cells and their average process lengths. Both the percentage of the processed cells and the length of the processes were increased by 2D-CM and 3D-CM, suggesting that BV-2 cells were activated by C6 conditioned media (Fig. 2b ii, iii).
Phagocytosis of BV-2 Cells in 2D Co-culture Assay
To investigate microglial phagocytosis of glioma cells, we explored the different co-culture assays to mimic glioma microenvironments during the various stages of tumor growth. We designed both 2D and 3D co-culture assays in this study. The 2D co-culture assay was based on a 2D controllable pattern of C6 cells, and 3D co-culture assay was based on the generation of 3D C6 cell spheroids. As shown in Fig. 3a , the invasion area of the C6 cells decreased significantly when C6 cells were co-cultured with BV-2 cells in the 2D co-culture assay for 2 days (Fig. 3c i, ii) , which suggests that the BV-2 cells could devour the C6 cells. Furthermore, we detected the expression of the phagocytosis-related markers CD11/b and CD68 of BV-2 cells. The results demonstrate that both markers were up-regulated in this system (Fig. 4) , appearing to indicating that the phagocytosis of BV-2 cells was enhanced by C6 cells in the 2D co-culture assay. However, this type of phagocytosis of BV-2 cells was not apparent in the 3D co-culture assay. As shown in Fig. 5c i, ii, the invasion distance and out-migration area of the C6 cells from the cell spheroid continually increased in the 3D co-culture with BV-2 cells. Accordingly, the expressions of CD11/b and CD68 in the BV-2 cells declined in this assay, which indicates the phagocytosis-related capability of BV-2 cells was inhibited in the 3D assay as compared to the 2D assay (Fig. 4) . These results show that the phagocytic effects of microglia to cancer were enhanced during the earlier stage of the neoplastic process of glioma and inhibited during the late stage.
BV-2 Cells Promoted Invasion of Glioma
In addition to the BV-2 cells' phagocytosis of C6 glioma cells, we also found that the BV-2 cells could promote the invasion of C6 cells. As shown in Fig. 3b , with the exception that the number of C6 cells declined in the 2D coculture with BV-2 cells, C6 cells were transformed from an ovate form to become longer and thinner with a fibroblast-like shape. And the ratio of their length to their width was between 2.5 and 4.3 at 1 day and 11 at 2 days (Fig. 3c  iii) , which exhibited more mesenchymal-like morphology; this kind of epithelial-to-mesenchymal transition-like (EMT-like) change (one of the features of tumor motility and invasiveness) was time-dependent. In the 3D co-culture assay, this EMT-like change of C6 cells became more apparent, and the ratio of length to width of the C6 cells increased to 5.5 at 1 day and 12 at 2 days (Fig. 5b, c iii) . In addition, the increase in the out-migration area and the distance of the C6 cell spheroids indicates that the invasiveness of the glioma was promoted by the BV-2 microglia cells.
It was noticed that the EMT degree of C6 cells differed in various pattern areas. As shown in Fig. 6a , the C6 cells at the edge of the 2D and 3D pattern assays exhibited more obvious EMT trends than the cells in the center area. The expression of the mesenchymal marker (vimentin) was also increased, consistent with the morphological changes (Fig. 6b) . To further confirm the relationship between EMT and the invasion of C6 cells by BV-2 cells, we investigated the expression of EMT and genes associated with invasiveness (Twist and MMP-9) in C6 cells using real-time polymerase chain reaction (PCR). The results demonstrate that both Twist and MMP-9 were up-regulated significantly in either the 2D or 3D co-culture with BV-2 microglial cells compared to C6 cell culture alone (Fig. 6c) .
Discussion
The exertion of migratory and phagocytic activity by microglia in glioma was first reported by Penfield in 1925 [24] . Since then, numerous studies have shown that microglia are found in high-grade malignant gliomas and form the major components of glioma-infiltrating cells [8] . Some studies have indicated that microglia play an immune defensive effect against glioma and inhibit the proliferation and growth of glioma [25] . However, most studies suggest that glioma-infiltrating microglia markedly increase glioma migration and invasion and support the promoting effect of microglia in tumorigenesis [10, 26, 27] . Microglial activities seem multifaceted during glioma progression. Therefore, to fully understand the bi-directional communications between microglia and gliomas, such relationships should be studied not only in malignant gliomas but also during the early stage of tumor progression, where many important questions remain to be answered. A major obstacle of investigations that seek to understand the functions of microglia remains a paucity of data to describe the dynamics of microglia-glioma cell interactions. Most findings concerning microglia-glioma cell interactions are based on ex vivo human or murine specimens harvested when the glioma tumor mass is grossly apparent in tumors abetted by immunosuppressive glioma-promoting microglia [7, 28] . Therefore, little data is available to compare the phenotypes and behavior of microglia at tumor onset and during the late stage of glioma progression [28] . Similarly, it is difficult to observe the dynamic process of tumor invasion with the Transwell or Boyden chamber assay, an in vitro model that has recently been widely adopted in the study of glioma invasion and migration [10, 29, 30] . Compared to the Transwell assay, the obvious advantages of the newly developed microfluidic technology are the manufacture of chips in various forms to meet different experimental requirements and the ability to observe cellular behavior dynamically, temporally, and spatially in a controlled microenvironment [31] .
In this study, we developed an unattached-cell comigration microfluidic assay to explore the intermigration between BV-2 and C6 cells. The microglial BV-2 and glioma C6 cells were separated by migration channels. The results demonstrate that the two types of cells were mutually attracted and migrated to each other through the channels (Fig. 2a) . In some in vivo studies, microglia were polarized and recruited by tumor-released chemokines such as colony-stimulating factor, monocyte chemotactic protein-1, hepatocyte growth factor, and glial cell line-derived neurotrophic factor [32, 33] and migrated to the tumor cells. The activated microglia released active substances such as granulocyte macrophage colony-stimulating factor that further increased glioma migration [10] . As in the study above, the two kinds of cells moved significantly toward each other in this co-cultured microfluidic system. The activation of BV-2 cells was accompanied by phenotype changes into a processed state (Fig. 2a) .
To further study the important interaction of BV-2 and C6 cells, we explored the immediate contacted co-culture assays. The 2D and 3D patterns of C6 were used to imitate the initiation stage (or early stage) and malignant stage (or (Fig. 1b-f) . In 2D co-culture assay, BV-2 cells congregated toward the tumor C6 cells and expressed increasing quantities of CD68 (phagocytosis) and CD11/b (adhesion) (Figs. 2a, 4) . These results suggest that, in the early stage of gliomas (glioma cells were scattered in the 2D co-culture system), the microglia could migrate to the site of the glioma and exhibit their immunological and phagocytotic ability to kill tumor cells (Fig. 3,4) . While in the 3D co-culture assay (wherein the glioma cells form a tumor mass), the expressions of CD68 and CD11/b in the microglia decreased and the phagocytotic ability decreased, indicating that the immune phagocytosis of microglia was inhibited during the late stage of tumor progression (Fig. 4) . This change in the immune response of microglia is in agreement with the pathologic results in vivo [33, 34] . This phenomenon might be induced by glioma stem cells, which are considered to contribute to the conversion of microglia from classically activated M1 to immunosuppressive M2 phenotypes, which impede the phagocytic ability of microglia [35] .
In addition to activation by phagocytosis, the BV-2 cells were found to promote the invasion of C6 cells in both 2D and 3D assays (Figs. 5, 6 ). This enhanced invasion capability in glioma is considered to be related to the EMT change of C6 cells, which is a crucial feature in tumor motility and invasiveness. EMT is a complicated biological cellular process that exhibits highly phenotypic plasticity, in which the cells lose their normal immobile and adhesion phenotype and acquire a mesenchymal phenotype to enhance their motility and invasiveness [36] [37] [38] [39] . The EMT change of C6 cells also was investigated in this study. The results show that the fluorescence intensity of vimentin in C6 cells, which is a classical mesenchymal marker of EMT, showed an obvious increase during stimulation of BV-2 cells. Furthermore, the RT-PCR results of the expression of Twist1 and MMP-9 in C6 cells demonstrate that both 3D and 2D microenvironments with microglia co-culture could promote glioma invasion and that the influence of these two factors can be overestimated (Fig. 6c) . Twist1 has been reported to promote EMT within a cancer cell in response to appropriate micro-environmental signals and lead to a rearrangement of the cytoskeleton of the cell. MMP-9 is an enzyme that belongs to the zinc-metalloproteinases family, which could degrade the extracellular matrix and enhance the migratory ability of the cells. Respectively, the same changing trend of these two genes in different C6 pattern assays also demonstrated a positive relationship between EMT and invasion.
In this study, we established three microfluidic cell culture assays to investigate the bi-directional relationship between microglia and glioma. The results demonstrate that microglia could be chemoattracted in the glioma microenvironment, which could enhance the recruitment and adherence of the microglia in the glioma area. After targeted enrichment, the microglia played bi-directional roles in brain tumorigenesis. In the 2D co-culture assay that was used to mimic the early stage of glioma growth, the microglia exhibited a phagocytic capacity and killed the glioma cells. However, the microglia cells lost their phagocytic activity and transformed from a proinflammatory and activated form into an immunosuppressive state in the 3D co-culture assay that was used to mimic the malignant stage of glioma. Furthermore, we found that microglia could contribute to tumor invasion and the acquisition of the EMT phenotype in the glioma microenvironment during all stages of tumor progression. In conclusion, we developed a potential quantitative method for in vitro study of glioma immunity and provided evidence for the duality of gliomaassociated microglia.
